Effect of erythromycin on Shigella infection of Caco-2 cells

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 2, 2000, Pages 139-145

  Honma, Yasuko ^a   Sasakawa, Chihiro ^b   Tsuji, Takao ^a   Iwanaga, Masaaki ^c  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Caco 2 cell; Erythromycin; Invasion; Shigella flexneri; Susceptibility; Type III secretion apparatus

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIOSTASIS; CELL INVASION; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; SHIGELLA FLEXNERI; SHIGELLOSIS; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BLOTTING, SOUTHERN; CACO-2 CELLS; CONGO RED; CULTURE MEDIA; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; SHIGELLA FLEXNERI; VIRULENCE;

EID: 0033972676     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00180-7     Document Type: Article

References (25)

1. Higa N., Iwanaga M., Utsunomiya A., Kuyyakanond T., Sithivong N., Wasito E.B., Toma C., Yamashiro T. Drug sensitivity of Vibrio cholerae and Shigella species in the world. Jpn. J. Trop. Med. Hyg. 23:1995;159-164.
2. Okajima S., Hori K., Miyaji H., Ukai S., Takayama Y., Yamagishita T. The treatment of bacillary dysentery with leucomycin and comparison of its clinical effects with other macrolide antibiotics. J. Jpn. Assoc. Inf. Dis. 40:1966;62-70.
3. Saito M., Yamaguchi T., Sato H. Clinical use of erythromycin estolate against bacillary dysentery. Jpn. J. A. Inf. D. 38:1964;327-332.
4. Ukai S., Hori K., Yamagishita T., Takayama Y., Miyaji H., Ono Y., Okajima S. Treatment of bacillary dysentery with erythromycin estolate (Ilosone). J. Jpn. Assoc. Inf. Dis. 39:1965;330-335.
5. Kadota J., Sakito P., Khono S., Sawa H., Mukae H., Oda H., Kawakami K., Fukushima K., Hiratani K., Hara K. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am. Rev. Respir. Dis. 147:1993;153-159.
6. Kudoh S., Uetake T., Hagiwara K., Hirayama M., Hus L.H., Kimura H., Sugiyama Y. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis. Jpn. J. Thorac. Dis. 25:1987;632-642.
7. Sawaki M., Mikami R., Mikasa K., Kunimatsu M., Ito S., Narita N. The long term chemotherapy with erythromycin in chronic lower respiratory tract infection - First report: comparing with amoxicillin. J. Jpn. Assoc. Inf. Dis. 60:1986;37-44.
8. Sawaki M., Mikami R., Mikasa K., Kunimatsu M., Ito S., Narita N. The long term chemotherapy with erythromycin in chronic lower respiratory tract infection-second report: including cases with Pseudomonas Infections. J. Jpn. Assoc. Inf. Dis. 60:1986;45-50.
9. Sakai T., Sasakawa C., Makino S., Kamata K., Yoshikawa M. Molecular cloning of a genetic determinant for congo red binding ability which is essential for virulence of Shigella flexneri. Infect. Immun. 51:1986;476-482.
10. Sasakawa C., Kamata K., Sakai T., Murayama S.Y., Makino S., Yoshikawa M. Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and congo red binding activity in Shigella flexneri. Infect. Immun. 51:1986;470-475.
11. Sasakawa C., Adler B., Tobe T., Okada N., Nagai S., Komatsu K., Yoshikawa M. Functional organization and nucleotide sequence of virulence region-2 on the large virulence plasmid in Shigella flexneri 2a. Mol. Microbiol. 3:1989;1191-1201.
12. Sasakawa C., Kamata K., Sakai T., Makino S., Yamada M., Okada N., Yoshikawa M. Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J. Bacteriol. 170:1988;2480-2484.
13. Sasakawa C., Komatsu K., Tobe T., Suzuki T., Yoshikawa M. Eight genes in region 5 that form an operon are essential for invasion of epithelial cells by Shigella flexneri 2a. J. Bacteriol. 175:1993;2334-2346.
14. Maurelli A.T., Blackmon B., Curtiss R. III. Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid. Infect. Immun. 43:1984;397-401.
15. Sasakawa C., Kamata K., Sakai T., Murayama S.Y., Makino S., Yoshikawa M. Molecular alteration of the 140-megadalton plasmid associated with loss of virulence and congo red binding activity in Shigella flexneri. Infect. Immun. 51:1986;470-475.
16. Bagdasarian, M. and Bagdasarian, M.M. (1994) Gene cloning and expression. In: Methods for General and Molecular Bacteriology (Gerhardt, P., Murray, R.G.E., Wood, W.A. and Krieg, N.R., Eds.), pp. 409-412. American Society for Microbiology, Washington, DC.
17. Sethabutr O., Venkatesan M., Murphy G.S., Eampokalap B., Hoge C.W., Escheverria P. Detection of Shigella and enteroinvasive Escherichia coli by amplification of the invasion plasmid antigen H DNA sequence in patients with dysentery. J. Infect. Dis. 167:1993;458-461.
18. Lampel K.A., Jagow J.S., Trucksess M., Hill W.E. Polymerase chain reaction for detection of invasive Shigella flexneri in food. Appl. Environ. Microbiol. 56:1990;1536-1540.
19. National Committee for Clinical Laboratory Standards (1997) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 4th edn., Approved Standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, PA.
20. Michel-Briand Y., Laporte J.M., Couetdic G., Sansonetti P.J. Elimination of a virulence plasmid from Shigella sonnei and Escherichia coli by antibiotics. Ann. Inst. Pasteur Microbiol. 137B:1986;291-295.
21. Greenberg R.N., Pearson R.D., Innes D.J., Sauer K.T., Halterman L.D., Guerrant R. Susceptibity of Shigella species to erythromycin. Antimicrob. Agents Chemother. 21:1982;347-348.
22. Sansonetti P.J., Ryter A., Clerc P., Maurelli A.T., Mounier J. Multiplication of Shigella flexneri within HeLa cells: Lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis. Infect. Immun. 51:1986;461-469.
23. Andrews G.P., Maurelli A.T. mxiA of Shigella flexneri 2a, which facilitates export of invasion plasmid antigens, encodes a homolog of the low-calcium response protein, LcrD, of Yersinia pestis. Infect. Immun. 60:1992;3287-3295.
24. Venkatesan M.M., Buysse J.M., Oaks E.V. Surface presentation of Shigella flexneri invasion plasmid antigens requires the products of the spa locus. J. Bacteriol. 174:1992;1990-2001.
25. Taylor D.N., Blaser M.J., Echeverria P., Pitarangsi C., Bodhidatta L., Wanf W.L. Erythromycin-resistant Campylobacter infections in Thailand. Antimicrob. Agents Chemother. 31:1987;438-442.